# Bayer Weimar GmbH und Co. KG – FDA Inspection, Sep 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/bayer-weimar-gmbh-und-co-kg/2dea6029-e51c-456e-b848-e0b82a40b1a0
Source feed: FDA_Inspections

> FDA inspection 1101920 of Bayer Weimar GmbH und Co. KG, September 13, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101920
- Company Name: Bayer Weimar GmbH und Co. KG
- Inspection Date: 2019-09-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1274501 - 2022-11-24
- FDA Inspection 948310 - 2015-11-05
- FDA Inspection 805216 - 2012-10-19
- FDA Inspection 636510 - 2009-12-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)

Company: https://www.keypedia.com/companies/bayer-weimar-gmbh-und-co-kg/b636d0d5-c5c8-417e-962a-955011f5ffdc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c